Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 441

Sort by

Sort Order Select

Journal Articles

A common TBP-binding site mutation elevates fetal hemoglobin levels by competitive globin switching change in β-thalassemia

Mengyang Song, Xiaolei Wei, Hualei Luo, Jueheng Wang, Yuhua Ye, Lang Qin, Chao Niu, Yong Long, Xingmin Wang, Congwen Shao, Miao Yu, Feng Gu, Xinhua Zhang, Xiangmin Xu

Blood Adv (2025) 9 (13): 3159–3169.

https://doi.org/10.1182/bloodadvances.2024013695

Published: 2025

Includes: Supplemental data

Journal Articles

Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females

Yohei Doi, Takayuki Hamano, Osamu Yamaguchi, Yoshitaka Isaka

Blood Adv (2025) 9 (13): 3202–3212.

https://doi.org/10.1182/bloodadvances.2025016320

Published: 2025

Includes: Supplemental data

Journal Articles

A road map for uniform, comprehensive long-term follow-up after curative therapy for sickle cell disease

Shalini Shenoy, Julie Kanter, Adetola Kassim, Courtney Fitzhugh, Elizabeth Stenger, Monica Bhatia, Lydia Pecker, Lakshmanan Krishnamurti, Allison A. King

Blood Adv (2025) 9 (12): 3090–3103.

https://doi.org/10.1182/bloodadvances.2024013953

Published: 2025

Includes: Supplemental data

Journal Articles

Long-term data needed for SCD gene therapy

Alexis Leonard

Blood Adv (2025) 9 (12): 3104–3105.

https://doi.org/10.1182/bloodadvances.2025016267

Published: 2025

Journal Articles

Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results

Blood Adv (2025) 9 (12): 3116–3127.

https://doi.org/10.1182/bloodadvances.2024015073

Published: 2025

Includes: Supplemental data

Journal Articles

Severe Parvovirus B19 Infection in Patients with Sickle Cell Disease Hospitalized in Intensive Care Unit

Segolene Gendreau, Louis-Marie Coupry, Pierre Cappy, Alexandra Beurton, Nicolas Verger, Anoosha Habibi, Maïté Agbakou, Sylvain Le Jeune, Laurent Argaud, Serge Barmo, Gauthier Blonz, Pierre Cougoul, Stéphanie Houcke, Antoine Lafarge, Arnaud Ly, Andréa Pastissier, Armand Mekontso Dessap, Slim Fourati, Nicolas de Prost

Blood Adv bloodadvances.2025015947.

https://doi.org/10.1182/bloodadvances.2025015947

Published: 2025

Includes: Supplemental data

Journal Articles

Neuroprotective, anti-inflammatory, and analgesic activity of palmitoylethanolamide in sickle cell mice

Donovan A. Argueta, Bryant Avalos, Yugal Goel, Huy Tran, Yannick Fotio, Daniele Piomelli, Nicholas V. DiPatrizio, Kalpna Gupta

Blood Adv (2025) 9 (12): 3056–3068.

https://doi.org/10.1182/bloodadvances.2024015439

Published: 2025

Includes: Supplemental data

Journal Articles

Cortisol in Sickle Cell Disease: A Systematic Review and Meta-Analysis

Kemar V. Prussien, Margaret Mary Burke, Kandace Gollomp, Rosalind J Wright, Alexis A. Thompson

Blood Adv bloodadvances.2024015425.

https://doi.org/10.1182/bloodadvances.2024015425

Published: 2025

Includes: Supplemental data

Journal Articles

Changes in acute care use among people with sickle cell disease after adoption of a prescription drug monitoring program

Blake T. McGee, Brandon K. Attell, James Marton, Adrienne Harris, Brett Alfrey, Lindsey L. Cohen, Angela B. Snyder

Blood Adv (2025) 9 (12): 3014–3023.

https://doi.org/10.1182/bloodadvances.2024013594

Published: 2025

Includes: Supplemental data

Journal Articles

Red blood cells with reduced deformability are selectively cleared from circulation in a mouse model

Emel Islamzada, Kerryn Matthews, Erik S. Lamoureux, Simon P. Duffy, Mark D. Scott, Hongshen Ma

Blood Adv (2025) 9 (12): 2988–2996.

https://doi.org/10.1182/bloodadvances.2024014100

Published: 2025

Includes: Supplemental data

Journal Articles

Triaging acute chest syndrome clinical decision-making using bedside SaO 2 /FiO 2 ratio

Austin Wesevich, Megan Woelkers, Ayodeji Adegunsoye, Adam J. Wesevich, Mark J. Ratain, Gabrielle Lapping-Carr

Blood Adv (2025) 9 (12): 2970–2979.

https://doi.org/10.1182/bloodadvances.2024015139

Published: 2025

Includes: Supplemental data

Journal Articles

Nitrated fatty acids protect against acute kidney injury in sickle cell disease

Mara Carreño, Diane Lenhart, Rajat Pant, Paritosh Mondal, Sonia R. Salvatore, Maria F. Pires, Enrico M. Novelli, Francisco J. Schopfer, Samit Ghosh, Dario A. Vitturi

Blood Adv (2025) 9 (12): 2886–2890.

https://doi.org/10.1182/bloodadvances.2024015038

Published: 2025

Includes: Supplemental data

Journal Articles

Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell disease

Kristine Karkoska, Seethal A. Jacob, Patrick T. McGann

Blood Adv (2025) 9 (11): 2857–2862.

https://doi.org/10.1182/bloodadvances.2025015822

Published: 2025

Journal Articles

National Alliance of Sickle Cell Centers Consensus Standards for Transition to Adult Care in Sickle Cell Disease

Stephanie Guarino, Akshat Jain, Mohan Madisetti, Kenneth A Rivlin, Payal Chandarana Desai, Julie Kanter, Sophie Lanzkron, Deepa G Manwani

Blood Adv bloodadvances.2025015909.

https://doi.org/10.1182/bloodadvances.2025015909

Published: 2025

Includes: Supplemental data

Journal Articles

Mitapivat metabolically reprograms human β-thalassemic erythroblasts, increasing their responsiveness to oxidation

Angela Siciliano, Angelo D’Alessandro, Alessandro Matte, Giovanni Bisello, Mariarita Bertoldi, Monika Dzieciatkowska, Amy Argabright, Richard Huot Pozzetto, Veronica Riccardi, Andrea Mattarei, Alberto Ongaro, Jacopo Ceolan, Roberta Russo, Leonardo Rivadeneyra, Megan Wind-Rotolo, Achille Iolascon, Carlo Brugnara, Lucia De Franceschi

Blood Adv (2025) 9 (11): 2818–2830.

https://doi.org/10.1182/bloodadvances.2024013591

Published: 2025

Includes: Supplemental data

Journal Articles

Implementing ASH’s guidelines for acute medical care for incarcerated children and adults with sickle cell disease

Michael R. DeBaun, Michelle Staples-Horne, Radha Sadacharan, Paula Braverman, Nirmish Shah, John Strouse, Deana Orsini, Charles Dudley Lee, Elizabeth S. Barnert

Blood Adv (2025) 9 (11): 2744–2750.

https://doi.org/10.1182/bloodadvances.2023012546

Published: 2025

Includes: Supplemental data

Journal Articles

BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice

Yoonjeong Jang, Ruopeng Feng, Lance E. Palmer, Thiyagaraj Mayuranathan, Yu Yao, Kalin Mayberry, Sheng Zhou, Jian Xu, Jeffrey M. Gossett, Guolian Kang, Yong Cheng, Jonathan S. Yen, Mitchell J. Weiss

Blood Adv (2025) 9 (11): 2722–2732.

https://doi.org/10.1182/bloodadvances.2024015574

Published: 2025

Includes: Supplemental data

Journal Articles

Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model

Fatima Trebak, Mohammad O. Sako, Steven P. Grover, Karnsasin Seanoon, Izabela Pawlinski, Chatphatai Moonla, Michael W. Henderson, Vimal K. Derebail, Dougald M. Monroe, Patrick Ellsworth, Rafal Pawlinski, Malgorzata Kasztan, Nigel S. Key

Blood Adv (2025) 9 (11): 2709–2721.

https://doi.org/10.1182/bloodadvances.2024015674

Published: 2025

Includes: Supplemental data

Journal Articles

DBA syndrome 2.0: Rpl11 mouse model revisited

Senthil Velan Bhoopalan, Marcin W. Wlodarski

Blood Adv (2025) 9 (11): 2706–2708.

https://doi.org/10.1182/bloodadvances.2025016115

Published: 2025

Journal Articles

A novel mouse model to study the effects of new therapies for Diamond-Blackfan anemia

Y. Lucy Liu, Nicholas Neoman, Kathleen M. Sakamoto

Blood Adv (2025) 9 (11): 2686–2690.

https://doi.org/10.1182/bloodadvances.2024015119

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A common TBP-binding site mutation elevates fetal hemoglobin levels by competitive globin switching change in β-thalassemia

Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females

A road map for uniform, comprehensive long-term follow-up after curative therapy for sickle cell disease

Long-term data needed for SCD gene therapy

Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results

Severe Parvovirus B19 Infection in Patients with Sickle Cell Disease Hospitalized in Intensive Care Unit

Neuroprotective, anti-inflammatory, and analgesic activity of palmitoylethanolamide in sickle cell mice

Cortisol in Sickle Cell Disease: A Systematic Review and Meta-Analysis

Changes in acute care use among people with sickle cell disease after adoption of a prescription drug monitoring program

Red blood cells with reduced deformability are selectively cleared from circulation in a mouse model

Triaging acute chest syndrome clinical decision-making using bedside SaO 2 /FiO 2 ratio

Nitrated fatty acids protect against acute kidney injury in sickle cell disease

Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell disease

National Alliance of Sickle Cell Centers Consensus Standards for Transition to Adult Care in Sickle Cell Disease

Mitapivat metabolically reprograms human β-thalassemic erythroblasts, increasing their responsiveness to oxidation

Implementing ASH’s guidelines for acute medical care for incarcerated children and adults with sickle cell disease

BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice

Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model

DBA syndrome 2.0: Rpl11 mouse model revisited

A novel mouse model to study the effects of new therapies for Diamond-Blackfan anemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only